Literature DB >> 16979538

Management of patients presenting with Sjogren's syndrome.

P J Venables1.   

Abstract

Sjogren's syndrome is an autoimmune exocrinopathy that predominantly affects salivary and lachrymal glands, leading to dry eyes and mouth. The most common clinical problems faced by the rheumatologist are those of dry eyes and mouth, parotid swelling, fatigue and extraglandular manifestations. The first stage in management is to make an accurate diagnosis based on the American/European consensus criteria. The most frequent differential diagnoses are dry eyes and mouth symptoms, a variant of chronic fatigue syndrome and fibromyalgia, and sialosis, which causes a non-inflammatory enlargement of the parotid glands. The mainstay of treatment for the sicca symptoms is local therapy, and that for the milder systemic symptoms is hydroxychloroquine. Steroids and immunosuppressive drugs are reserved for more severe extraglandular disease. In spite of intensive research in other systemic treatments including biologic therapies, there is limited evidence to support their use in routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979538     DOI: 10.1016/j.berh.2006.05.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  12 in total

1.  Evaluation of patients with dry eye for presence of underlying Sjögren syndrome.

Authors:  Esen Karamursel Akpek; Alena Klimava; Jennifer E Thorne; Don Martin; Kaevalin Lekhanont; Ann Ostrovsky
Journal:  Cornea       Date:  2009-06       Impact factor: 2.651

2.  Hypokalemic periodic paralysis in Sjogren's syndrome secondary to distal renal tubular acidosis.

Authors:  Hakkı Yılmaz; Mustafa Kaya; Mustafa Özbek; Kemal ÜUreten; İ Safa Yıldırım
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

3.  [Autoimmune sialadenitis].

Authors:  O Guntinas-Lichius; A Vissink; S Ihrler
Journal:  HNO       Date:  2010-03       Impact factor: 1.284

4.  Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome.

Authors:  Sule Yavuz; Esra Asfuroğlu; Muge Bicakcigil; Ebru Toker
Journal:  Rheumatol Int       Date:  2010-03-23       Impact factor: 2.631

5.  Anti-SSA/SSB-negative primary Sjögren's syndrome presenting with hypokalemia: A case report.

Authors:  Hai-Yan Tu; Shu-Ling Yue; Li-Jun Mou
Journal:  World J Emerg Med       Date:  2022

6.  Low-level laser therapy for xerostomia in primary Sjögren's syndrome: a randomized trial.

Authors:  Tania Fidelix; Adriano Czapkowski; Sergio Azjen; Adagmar Andriolo; Pedro Horvath Neto; Virgínia Trevisani
Journal:  Clin Rheumatol       Date:  2017-11-09       Impact factor: 2.980

Review 7.  Hypokalemic rhabdomyolysis: an unusual presentation of Sjogren's syndrome.

Authors:  Eya Cherif; Lamia Ben Hassine; Ines Kechaou; Narjess Khalfallah
Journal:  BMJ Case Rep       Date:  2013-10-28

Review 8.  Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly.

Authors:  Kristine P Ng; David A Isenberg
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

9.  Chemosensory dysfunction, Oral disorders and Oral health-related quality of life in patients with primary Sjögren's syndrome: comparative cross-sectional study.

Authors:  Mirjana Šijan Gobeljić; Vera Milić; Nada Pejnović; Nemanja Damjanov
Journal:  BMC Oral Health       Date:  2020-07-03       Impact factor: 2.757

10.  Chloroquine Protects Human Corneal Epithelial Cells from Desiccation Stress Induced Inflammation without Altering the Autophagy Flux.

Authors:  Shivapriya Shivakumar; Trailokyanath Panigrahi; Rohit Shetty; Murali Subramani; Arkasubhra Ghosh; Nallathambi Jeyabalan
Journal:  Biomed Res Int       Date:  2018-11-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.